130 related articles for article (PubMed ID: 22461310)
1. In HIV-infected patients, some differential alterations of CD4 and CD8 T cell homeostasis may not be restored by ≥ 7 years of highly active antiretroviral therapy, in spite of good CD4 T cell repopulation.
Bordoni V; Agrati C; Rinaldi A; Viola D; De Simone G; Gioia C; Martini F
J Antimicrob Chemother; 2012 Jul; 67(7):1802-4. PubMed ID: 22461310
[No Abstract] [Full Text] [Related]
2. Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration.
Méndez-Lagares G; García-Pergañeda A; del Mar del Pozo-Balado M; Genebat M; Ruiz-Mateos E; García García M; Muñoz-Fernández MÁ; Pacheco YM; Leal M
J Antimicrob Chemother; 2012 May; 67(5):1228-37. PubMed ID: 22287235
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
4. Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected Indian individuals.
Mojumdar K; Vajpayee M; Chauhan NK; Singh A; Singh R; Kurapati S
Cytometry B Clin Cytom; 2012 Jan; 82(1):43-53. PubMed ID: 21695776
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.
Benito JM; Lopez M; Lozano S; Ballesteros C; Capa L; Martinez P; Gonzalez-Lahoz J; Soriano V
J Infect Dis; 2005 Dec; 192(12):2142-6. PubMed ID: 16288380
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C
AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348
[TBL] [Abstract][Full Text] [Related]
7. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
Kolber MA
AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
[TBL] [Abstract][Full Text] [Related]
8. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
[TBL] [Abstract][Full Text] [Related]
9. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
10. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
Lepej SZ; Begovac J; Vince A
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):351-9. PubMed ID: 16553807
[TBL] [Abstract][Full Text] [Related]
11. Turnover of lymphocytes and conceptual paradigms in HIV infection.
Silvestri G; Feinberg MB
J Clin Invest; 2003 Sep; 112(6):821-4. PubMed ID: 12975464
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
[TBL] [Abstract][Full Text] [Related]
14. Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
[TBL] [Abstract][Full Text] [Related]
15. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults.
Sainz T; Serrano-Villar S; Díaz L; González Tomé MI; Gurbindo MD; de José MI; Mellado MJ; Ramos JT; Zamora J; Moreno S; Muñoz-Fernández MA
AIDS; 2013 Jun; 27(9):1513-6. PubMed ID: 23435292
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy.
Petrovas C; Mueller YM; Katsikis PD
Cell Death Differ; 2005 Aug; 12 Suppl 1():859-70. PubMed ID: 15818412
[No Abstract] [Full Text] [Related]
17. To kill or be killed: how HIV exhausts the immune system.
Gougeon ML
Cell Death Differ; 2005 Aug; 12 Suppl 1():845-54. PubMed ID: 15832178
[No Abstract] [Full Text] [Related]
18. Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment.
Hua W; Jiao Y; Zhang H; Zhang T; Chen D; Zhang Y; Chen X; Wu H
Immunol Invest; 2012; 41(1):1-14. PubMed ID: 21563924
[TBL] [Abstract][Full Text] [Related]
19. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
[TBL] [Abstract][Full Text] [Related]
20. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
